These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15830061)

  • 41. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
    Francis HP; Wade DT; Turner-Stokes L; Kingswell RS; Dott CS; Coxon EA
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1547-51. PubMed ID: 15489384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A; Cinone N; Panza F; Letizia S; Santoro L; Lozupone M; Daniele A; Picelli A; Baricich A; Intiso D; Ranieri M
    Drugs; 2019 Feb; 79(2):143-160. PubMed ID: 30623347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A; Vallies G; Chemello E; Gavras A; Castellazzi P; Meschieri A; Serina A; Gandolfi M; Baricich A; Santamato A; Cisari C; Smania N
    J Rehabil Med; 2017 May; 49(5):410-415. PubMed ID: 28471469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors.
    Franceschini M; Iocco M; Molteni F; Santamato A; Smania N;
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):525-33. PubMed ID: 24963604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of video clip analysis on effect of botulinum toxin-A injection for post-stroke upper limb spasticity.
    Kim WJ; Kumthornthip W; Oh BM; Yang EJ; Paik NJ
    Toxins (Basel); 2013 May; 5(5):983-91. PubMed ID: 23666198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK; Brashear A; Jozefczyk P; Reding M; Alexander D; Good D; Walcott JM; Jenkins SW; Turkel C; Molloy PT
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1063-9. PubMed ID: 15241751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Ranieri M; Frisardi V; Micello MF; Filoni S; Fortunato F; Intiso D; Basciani M; Logroscino G; Fiore P
    J Neural Transm (Vienna); 2013 Mar; 120(3):469-76. PubMed ID: 22955957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A; McAfee AL; Kuhn ER; Fyffe J
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The features of botulinum therapy for different patterns of poststroke spasticity].
    Krylova LV; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):42-48. PubMed ID: 28374692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm muscles.
    Girlanda P; Quartarone A; Sinicropi S; Nicolosi C; Roberto ML; Picciolo G; Macaione V; Battaglia F; Ruggeri M; Messina C
    Neuroreport; 1997 Sep; 8(14):3039-44. PubMed ID: 9331911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
    Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
    J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upper Limb Motor Function Affects the Outcome after Treatment with Botulinum Toxin A.
    Fujimura K; Kagaya H; Onaka H; Nagasawa N; Ishihara A; Okochi Y; Yamada M; Tanikawa H; Kanada Y; Saitoh E
    Eur Neurol; 2019; 81(1-2):30-36. PubMed ID: 31013501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does botulinum toxin improve the function of the patient with spasticity after stroke?
    Cardoso E; Pedreira G; Prazeres A; Ribeiro N; Melo A
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):592-5. PubMed ID: 17876396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.